Department of Trauma Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Division of Trauma, Emergency Surgery and Surgical Critical Care, Massachusetts General Hospital, Boston, MA, United States.
Eur J Trauma Emerg Surg. 2022 Oct;48(5):4297-4304. doi: 10.1007/s00068-022-01938-7. Epub 2022 Mar 10.
Emergency physicians and trauma surgeons are increasingly confronted with pre-injury direct oral anticoagulants (DOACs). The objective of this study was to assess if pre-injury DOACs, compared to vitamin K antagonists (VKA), or no oral anticoagulants is independently associated with differences in treatment, mortality and inpatient rehabilitation requirement.
We performed a review of the prospectively maintained institutional trauma registry at an urban academic level 1 trauma center. We included all geriatric patients (aged ≥ 65 years) with tICH after a fall, admitted between January 2011 and December 2018. Multivariable logistic regression analysis controlling for demographics, comorbidities, vital signs, and tICH types were performed to identify the association between pre-injury anticoagulants and reversal agent use, neurosurgical interventions, inhospital mortality, 3-day mortality, and discharge to inpatient rehabilitation.
A total of 1453 tICH patients were included (52 DOAC, 376 VKA, 1025 control). DOAC use was independently associated with lower odds of receiving specific reversal agents [odds ratio (OR) 0.28, 95% confidence interval (CI) 0.15-0.54] than VKA patients. DOAC use was independently associated with requiring neurosurgical intervention (OR 3.14, 95% CI 1.36-7.28). VKA use, but not DOAC use, was independently associated with inhospital mortality, or discharge to hospice care (OR 1.62, 95% CI 1.15-2.27) compared to controls. VKA use was independently associated with higher odds of discharge to inpatient rehabilitation (OR 1.41, 95% CI 1.06-1.87) compared to controls.
Despite the higher neurosurgical intervention rates, patients with pre-injury DOAC use were associated with comparable rates of mortality and discharge to inpatient rehabilitation as patients without anticoagulation exposure. Future research should focus on risk assessment and stratification of DOAC-exposed trauma patients.
越来越多的急诊医师和创伤外科医师会遇到受伤前直接口服抗凝剂(DOAC)的情况。本研究的目的是评估受伤前 DOAC 与维生素 K 拮抗剂(VKA)或无口服抗凝剂相比,是否与治疗方法、死亡率和住院康复需求的差异独立相关。
我们对一家城市一级创伤中心前瞻性维护的机构创伤登记处进行了回顾性研究。我们纳入了所有 2011 年 1 月至 2018 年 12 月期间因跌倒导致 tICH 的老年患者(年龄≥65 岁)。使用多变量逻辑回归分析控制人口统计学、合并症、生命体征和 tICH 类型,以确定受伤前抗凝剂与逆转剂使用、神经外科干预、住院期间死亡率、3 天死亡率和出院至住院康复之间的关系。
共纳入 1453 例 tICH 患者(52 例 DOAC,376 例 VKA,1025 例对照)。与 VKA 患者相比,DOAC 患者接受特定逆转剂的可能性更低(比值比[OR]0.28,95%置信区间[CI]0.15-0.54)。DOAC 使用与需要神经外科干预(OR3.14,95%CI1.36-7.28)独立相关。与对照组相比,VKA 使用(但不是 DOAC 使用)与住院期间死亡率或临终关怀出院相关(OR1.62,95%CI1.15-2.27)。与对照组相比,VKA 使用与更高的住院康复出院几率相关(OR1.41,95%CI1.06-1.87)。
尽管神经外科干预率较高,但与无抗凝暴露的患者相比,受伤前使用 DOAC 的患者的死亡率和住院康复出院率相当。未来的研究应侧重于评估和分层 DOAC 暴露的创伤患者的风险。